Can this man bring down the cost of some of the most expensive and hope-inspiring new therapies on the market?
I recently had the pleasure of sitting down with Fabian Gerlinghaus, CEO of Cellares. They are working on closed-system full automation to manufacture cell therapies.
This was at JPM Week 2025 in San Francisco.
I hope you enjoy watching!
Yours sincerely,
Dr. Adil Ali
Allucent are helping small- to mid-sized biotechs stay nimble.
Ever thought a probiotic could help manage blood sugar by stimulating GLP-1?
Peter DeYoung lends insights on the strategic approach behind Piramal Phama’s expansion and growth.
Shashi Shankar explains how his app unifies patients' scattered medical records all together, and what that has to do with the 21st Century Cures Act.
